Richard M. Ginther
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Richard M. Ginther has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Joseph M. Forbess
Division of Pediatric Cardiothoracic Surgery Southwestern Medical Center and Children's Medical Center University of Texas Dallas Texas
1 shared publicationR Cruz
Division of Pediatric Cardiothoracic Surgery, University of Texas Southwestern Medical Center and Children’s Medical Center, Dallas, Texas, USA
1 shared publicationR Gorney
Division of Pediatric Cardiothoracic Surgery, University of Texas Southwestern Medical Center and Children’s Medical Center, Dallas, Texas, USA
1 shared publicationRonald Gorney
Division of Pediatric Cardiothoracic Surgery Southwestern Medical Center and Children's Medical Center University of Texas Dallas Texas
1 shared publication
Latest Publications
- Open Access
- 15 March 2013
- Published by EDP Sciences in The Journal of ExtraCorporeal Technology
- Vol. 45 (1) , 46-50
Use of del Nido Cardioplegia Solution and a Low-Prime Recirculating Cardioplegia Circuit in Pediatrics
The evolution of myocardial protection techniques has been both the source of milestone advancements and controversial debate in cardiac surgery. Our institution has modified a low-prime cardioplegia system (CPS) and adopted a single-dose cardioplegia solution (del Nido cardioplegia) for our congenital heart disease population. The goal of this article is to describe our CPS and outline our myocardial protection protocol. These techniques have allowed us to minimize circuit surface area, operate uninterrupted, and safely protect the myocardium during extended ischemic periods.
- 15 March 2013
- Published by EDP Sciences in The Journal of ExtraCorporeal Technology
- Vol. 45 (1) , 46-50
Open AccessUse of del Nido Cardioplegia Solution and a Low-Prime Recirculating Cardioplegia Circuit in Pediatrics
The evolution of myocardial protection techniques has been both the source of milestone advancements and controversial debate in cardiac surgery. Our institution has modified a low-prime cardioplegia system (CPS) and adopted a single-dose cardioplegia solution (del Nido cardioplegia) for our congenital heart disease population. The goal of this article is to describe our CPS and outline our myocardial protection protocol. These techniques have allowed us to minimize circuit surface area, operate uninterrupted, and safely protect the myocardium during extended ischemic periods.
- 28 February 2013
- Published by SAGE Publications in Perfusion
- Vol. 28 (3) , 194-199
A clinical evaluation of the Maquet Quadrox-i Neonatal oxygenator with integrated arterial filter
High-performance, low-prime-volume oxygenators for the pediatric patient population have become a growing market among manufacturers. In the summer of 2011, our institution clinically evaluated the performance of the newly released Maquet Quadrox-i Neonatal oxygenator with integrated arterial filter. The static priming volume, including the integrated arterial filter, is 40 ml and the maximum rated blood flow is 1.5 liters per minute (LPM). The device was used on seven pediatric patients, ranging from 3.2 to 14 kg, undergoing various congenital heart defect repairs. Data were collected to calculate gas transfer, trans-oxygenator pressure drop, and heat exchange performance. The mean cardiopulmonary bypass time was 85 minutes and the mean cross-clamp time was 56 minutes. The average oxygen transfer was 34.3 ± 22.8 ml/O2/min and increased with both blood flow and FiO2. The average carbon dioxide transfer was 22.3 ± 17.8 ml/min and increased with both blood flow and gas sweep to blood flow ratio. The average trans-oxygenator pressure drop per blood flow was 53.3 ± 15.5 mmHg/L/min and increased with flow. The average heat exchanger performance factor was 47.6 ± 11.6% and decreased with flow. The heat exchange performance factor at maximum observed clinical flow, 1.42 LPM, was 36.4%. During this evaluation, the Maquet Quadrox-i Neonatal oxygenator adequately performed within its operational flow in the clinical setting.
- 28 February 2013
- Published by SAGE Publications in Perfusion
- Vol. 28 (3) , 194-199
A clinical evaluation of the Maquet Quadrox-i Neonatal oxygenator with integrated arterial filter
High-performance, low-prime-volume oxygenators for the pediatric patient population have become a growing market among manufacturers. In the summer of 2011, our institution clinically evaluated the performance of the newly released Maquet Quadrox-i Neonatal oxygenator with integrated arterial filter. The static priming volume, including the integrated arterial filter, is 40 ml and the maximum rated blood flow is 1.5 liters per minute (LPM). The device was used on seven pediatric patients, ranging from 3.2 to 14 kg, undergoing various congenital heart defect repairs. Data were collected to calculate gas transfer, trans-oxygenator pressure drop, and heat exchange performance. The mean cardiopulmonary bypass time was 85 minutes and the mean cross-clamp time was 56 minutes. The average oxygen transfer was 34.3 ± 22.8 ml/O2/min and increased with both blood flow and FiO2. The average carbon dioxide transfer was 22.3 ± 17.8 ml/min and increased with both blood flow and gas sweep to blood flow ratio. The average trans-oxygenator pressure drop per blood flow was 53.3 ± 15.5 mmHg/L/min and increased with flow. The average heat exchanger performance factor was 47.6 ± 11.6% and decreased with flow. The heat exchange performance factor at maximum observed clinical flow, 1.42 LPM, was 36.4%. During this evaluation, the Maquet Quadrox-i Neonatal oxygenator adequately performed within its operational flow in the clinical setting.